MARKET WIREYahoo • 4d ago
Natural Health Trends: Q3 Earnings Snapshot(AP) — ROLLING HILLS ESTATES, Calif. (AP) — Natural Health Trends Corp.
Why NHTC Stock dropped -8.01% Today — RQD Quant Desk Flash
$0.77 -8.01% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $0.76
Natural Health Trends Corp. (NHTC) carries a Roarable Rating of E (Strong Sell) with 27/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE E • RED ALERT
Cap $6.6M
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $0.76 (-1.63%)🧬 Dilution Drag (+1.28% YoY Shares)⚙️ Cash Engine: 3/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (27/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-10.3% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • E
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw E · Rk E
Each axis scored 0–20
12M PRICE TARGET CONE-14.3% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for NHTC)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (27/100 Composite)
🔍 WHY NHTC SCORES 27/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+11/20 pts (41% of score)
20D Institutional Volume Accumulation (±12.5% realized swing band)
▲ #2 Bullish Driver: Macro Regime Fit+8/20 pts (30% of score)
FRED Regime × Technicals: 2% of 52W Range • RSI-14 at 28.4 (OVERSOLD (<32))
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)
Dilution Drag (+1.28% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade E$0.93+4.3% Next Q
35
Q2 (-2Q)Grade E$0.97-19.6% Next Q
32
Q3 (-1Q)Grade E$0.78-1.3% Next Q
30
CurrentGrade E$0.77-10.3% Hist 90D α
27
Trajectory: E (35) → E (27)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a NHTC Turnaround Squeeze
While NHTC currently carries a cautious 27/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Consumer Discretionary with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.21) and Max Pain ($0.81) forces dealer call-delta covering toward $4.66.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.28% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $NHTC• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “NHTC Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why NHTC Stock dropped -8.01% Today — RQD Quant Desk Flash
Natural Health Trends Corp. (NHTC) dropped -8.01% to $0.77, trading at 2% of its 52-week range ($0.75 – $4.44). Stretched risk/reward at current multiples (-9% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 2% of its 52-week range ($0.75 – $4.44) with RSI-14 at 28.4 (OVERSOLD (<32)).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $0.77 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 73.5% gross margin and $0 annual free cash flow.
Live NHTC Headlines & Catalysts
MARKET WIRESeekingAlpha • 4d ago
Natural Health Trends Corp. (NHTC) Q3 2026 Earnings Call Prepared Remarks TranscriptNatural Health Trends Corp. (NHTC) Q3 2026 Earnings Call October 28, 2026 11:30 AM EDTCompany ParticipantsMichelle Glidewell - Senior Manager of NHT Global...
RISK WATCHYahoo • 4d ago
Natural Health Trends Reports Third Quarter 2026 Financial ResultsCompany successfully held its 25th anniversary celebration in Hong Kong in AugustActive Member count up, revenue steady with prior quarterOperating loss narrowed 57% compared to prior quarterBoard of Directors authorized
RISK WATCHBenzinga • 4d ago
Natural Health Trends Q3 EPS $(0.03) Up From $(0.04) YoY, Sales $7.560M Down From $9.477M YoYNatural Health Trends (NASDAQ:NHTC) reported quarterly losses of $(0.03) per share. This is a 25 percent increase over losses of $(0.04) per share from the same period last year. The company reported $7.560 million in
MARKET WIREYahoo • 11d ago
Natural Health Trends to Report Third Quarter 2026 Financial Results on October 28thLOS ANGELES, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness, and “quality of life” produ
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring NHTC)
- ✓Walkthrough of NHTC's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
NHTC // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -75.32%⚡ TESTING RESISTANCE
2026-10-30O $0.76H $0.80L $0.75C $0.77VOL 45.9K
RES: $0.82SUP: $0.47SMA50: $1.21SMA200: $2.31
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
NHTC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. -7.4% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on NHTC today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for NHTC. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for NHTC today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (NHTC)
Consumer Discretionary Rank #978 of 1011
⚔️ EDUC vs NHTC Full Matrix →
1. Head-to-Head Consumer Discretionary Peer Comparison (NHTC vs. EDUC, HYFM, BRLT, ELA)
Industry: Consumer Specialties (11 Tracked Issuers)Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, Natural Health Trends Corp. (NHTC) ranks #978 by composite RQD confidence (27/100, grade E) and #951 by equity capitalization ($6.6M). Within this direct 5-issuer industry benchmark cohort, EDUC leads on earnings valuation at 3.8x trailing P/E, while ELA leads on capital efficiency and profitability with 20.7% ROIC and 22.4% gross margin. ELA currently holds the highest overall quantitative score in the immediate peer group at 70/100 (B-) compared with NHTC at 27/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| NHTC
ACTIVE
Natural Health Trends Corp. | E | 27/100 | — | 73.5% | -8.6% | -8.01% | $6.6M | Benchmark Subject |
| EDUC Educational Development Corporation | C- | 61/100 | 3.8x | 59.4% | 5.1% | +0.97% | $8.9M | /educ-vs-nhtc → |
| HYFM Hydrofarm Holdings Group Inc. | D- | 37/100 | — | 11.3% | -35.0% | -5.45% | $3.8M | /hyfm-vs-nhtc → |
| BRLT Brilliant Earth Group Inc. (Class A) | D | 47/100 | — | 57.5% | -35.0% | +2.58% | $161.9M | /brlt-vs-nhtc → |
| ELA Envela Corporation | B- | 70/100 | 20.2x | 22.4% | 20.7% | +2.15% | $295.5M | /ela-vs-nhtc → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000912061In its most recent audited fiscal period (FY2025, filed 2025-12-31), Natural Health Trends Corp. (NHTC) reported GAAP revenue of $39.8M (-7.4% vs. FY2024 revenue of $43.0M , and -9.4% cumulative change since FY2023) , GAAP net income of -$882.0K, operating cash flow of -$6.0M, and free cash flow of -$6.1M (-77.1% YoY). On the balance sheet, NHTC closed FY2025 with $38.4M in total assets against $0 in total debt (Altman Z-Score: 0.46, Piotroski F-Score: 2/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $39.8M | -$882.0K | -$6.0M | -$6.1M | $38.4M | — |
| FY2024 (FY) | 2024-12-31 | $43.0M | $572.0K | -$3.4M | -$3.4M | $55.4M | — |
| FY2023 (FY) | 2023-12-31 | $43.9M | $568.0K | -$4.3M | -$4.3M | — | — |
3. NHTC Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs NHTC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Natural Health Trends Corp. (NASDAQ: NHTC) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 27/100 at a spot price of $0.77 (-8.01% 1D, market cap $6.6M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 5/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 3/20. Across 1011 tracked Consumer Discretionary issuers, NHTC ranks #978 in composite RQD confidence.
How does NHTC compare to EDUC and HYFM in the Consumer Discretionary sector?
Within the Consumer Discretionary sector (Consumer Specialties), NHTC carries a Roarable E (27/100 RQD), trailing P/E of N/A, gross margin of 73.5%, and ROIC of -8.6%. By comparison, EDUC (Educational Development Corporation) holds a C- grade (61/100 RQD, P/E 3.8x, ROIC 5.1%, cap $8.9M) and HYFM (Hydrofarm Holdings Group Inc.) posts a D- grade (37/100 RQD, P/E N/A, ROIC -35.0%, cap $3.8M). Among the 5-stock peer group, EDUC leads on earnings multiple (3.8x) while ELA leads on capital efficiency (20.7% ROIC).
What are the biggest fundamental strengths and SEC risk factors for NHTC?
Per NHTC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000912061), Natural Health Trends Corp. generated $39.8M in revenue (-7.4% YoY), -$882.0K in net income, and -$6.1M in free cash flow against $38.4M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is NHTC trading relative to its 50-day, 200-day, and 52-week technical levels?
NHTC last traded at $0.77 (-8.01% on volume of 81,522 shares), positioning the stock -36.36% below its 50-day simple moving average ($1.21) and -66.67% below its 200-day simple moving average ($2.31). Across its 52-week range of $0.75 to $4.44, NHTC sits at the 0.5% percentile with a 14-day RSI of 28.4 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.00 to $0.87).
NHTC Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is NHTC stock moving today?
Why NHTC Stock dropped -8.01% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-9% return on capital) under elevated 10-year interest-rate pressure.